This investigation represents the first effort to examine gene signatures associated with ACD in HIRI, identifying LCP1, SLC16A3, and RGS2 as novel biomarkers and establishing a foundation for elucidating their regulatory functions in HIRI pathogenesis. The gene discussed is SLC16A3; the disease is granular corneal dystrophy type II.